Explorer les evidences

15 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 15.0% for those with no/primary education level, 16.7% for those with secondary-1st cycle education, and 9.5% for those with secondary-2nd cycle or university education in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

14,5 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 14.5% for those aged 9–10 years, 16.0% for those aged 11–14 years, and 14.0% for those aged 15–19 years in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

9,1 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 9.1% for those attending HIV care facilities located in Abidjan and 20.4% for those attending facilities outside Abidjan in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

14,7 %Among 659 AGLHIV in Côte d'Ivoire participating in the COVADOCI study, 97 (14.7%) had received at least one HPV vaccine dose.

Côte d'Ivoireinfection à HPVHAL · Unilimdocument de 69 observations

20 %Less than one-fifth of AGLHIV received at least one dose of HPV vaccine in Côte d'Ivoire in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

13,2 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 13.2% for those who never accessed the internet, 13.4% for those accessing it less than once per week, and 16.5% for those accessing it at least once per week in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

13,1 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 13.1% for those who had never attended a focus group on sexual education and 16.5% for those who had attended such a focus group in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

8,3 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 8.3% for those whose parent/legal guardian was not aware of cervical cancer, 17.4% for those whose parent/legal guardian was aware, and 4.1% for those with non-applicable status in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

13,5 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 13.5% for those who did not identify HPV as cervical cancer aetiology and 35.1% for those who did identify HPV as cervical cancer aetiology in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations

8,9 %Among adolescent girls living with HIV in Côte d'Ivoire, 8.9% reported parents' refusal as a barrier to HPV vaccination.

Côte d'Ivoireinfection à HPV · VIH/sidaobservé 2024–2025HAL · Unilimdocument de 69 observations

14,7 %Among 659 adolescent girls living with HIV in Côte d'Ivoire, 97 (14.7%) received at least one dose of HPV vaccine.

Côte d'Ivoireinfection à HPVHAL · Unilimdocument de 69 observations

85,3 %Among 659 AGLHIV in Côte d'Ivoire participating in the COVADOCI study, 562 (85.3%) were not vaccinated against HPV.

Côte d'Ivoireinfection à HPVHAL · Unilimdocument de 69 observations

85,4 %Among adolescent girls living with HIV in Côte d'Ivoire, 85.4% reported lack of information about the HPV vaccine as a barrier to vaccination.

Côte d'Ivoireinfection à HPV · VIH/sidaobservé 2024–2025HAL · Unilimdocument de 69 observations